Global Assisted Reproductive Technology Market Report and Forecast 2024-2032

Global Assisted Reproductive Technology Market Report and Forecast 2024-2032


Global Assisted Reproductive Technology Outlook

The global assisted reproductive technology market size was valued at USD 14.8 billion in 2023, driven by the increasing infertility issues across the globe. The market size is anticipated to grow at a CAGR of 4.4% during the forecast period of 2024-2032 to achieve a value of USD 21.8 billion by 2032.

Assisted Reproductive Technology: Introduction

Assisted Reproductive Technology (ART) encompasses medical procedures that aid in achieving pregnancy when natural conception is challenging. Techniques include in vitro fertilization (IVF), where an egg is fertilized outside the body, and intracytoplasmic sperm injection (ICSI), where a single sperm is injected into an egg. ART assists couples facing fertility issues, allowing for conception and pregnancy by overcoming barriers such as infertility, genetic disorders, or reproductive challenges.

Key Trends in the Global Assisted Reproductive Technology Market

The global Assisted Reproductive Technology (ART) market has witnessed dynamic trends reshaping the landscape of fertility treatments. Technological strides have led to continuous refinements in ART techniques, such as enhanced embryo culture and advanced genetic screening.

A notable shift in societal attitudes is evident, with increased acceptance of third-party reproduction methods, including egg and sperm donation, surrogacy, and gestational carriers. The rising age of first-time parents has propelled a surge in couples seeking ART solutions to address age-related fertility challenges. Globalization of ART services is on the rise, with individuals seeking treatments in countries offering advanced technologies or more favourable regulations.

There is a growing emphasis on addressing male infertility, leading to advancements in diagnostics and treatments for male reproductive health. Increasing regulatory oversight reflects a commitment to maintaining ethical standards and patient safety. Some regions have witnessed expanded insurance coverage for fertility treatments, contributing to greater accessibility.

The integration of artificial intelligence in fertility clinics is revolutionizing data analysis, predictive modelling, and treatment optimization. Education and awareness initiatives have played a crucial role in informing the public about fertility preservation options and the availability of ART services.

The impact of the COVID-19 pandemic has been noteworthy, causing temporary disruptions in fertility clinic operations and treatment plans, followed by a resurgence in demand. These multifaceted trends collectively underscore the evolving landscape of ART, emphasizing innovation, accessibility, and a broader understanding of reproductive health. For the latest insights in 2023, consulting recent industry reports and market analyses is advised.

Global Assisted Reproductive Technology Market Segmentation

Market Breakup by Procedure
  • Fresh Donor
  • Fresh Nondonor
  • Frozen Donor
  • Frozen Nondonor
  • Embryo/Egg Banking
Market Breakup by Age
  • Women Younger Than Age 35
  • Women Older Than Age 35
Market Breakup by Application
  • Artificial Insemination - Intrauterine Insemination (AI-IUI)
  • Frozen Embryo Replacement (FER)
  • Surrogacy
  • Ovulation Induction
  • Others
Market Breakup by End User
  • Hospitals
  • Fertility Clinics
  • Others
Market Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Global Assisted Reproductive Technology Market Overview

The ART market has seen increased demand due to factors such as delayed parenthood, rising infertility rates, and advancements in reproductive technologies. Procedures like in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) have become more prevalent in addressing fertility challenges.

The United States has led the assisted reproductive technology market share owing to pioneering research and development in reproductive technologies and fertility treatments.

There is a high level of awareness and acceptance of ART procedures among the U.S. population, leading to a robust demand for these services. Moreover, the country's advanced healthcare infrastructure supports the widespread availability and accessibility of ART services. Some insurance plans in the U.S. cover fertility treatments as well, making these services more financially accessible to a larger population.

We can expect the Asia Pacific (APAC) region to grow rapidly in the forecast period. The implementation of awareness campaigns to educate the public about infertility, available treatments, and the success rates of ART procedures are some of the major factors for growth.

There has been regular development and enhancement of healthcare infrastructure to provide state-of-the-art fertility clinics and laboratories equipped with the latest technologies. Implementing measures to make ART more affordable and accessible to a wider demographic, possibly through insurance coverage or government initiatives is also in the works.

Global Assisted Reproductive Technology Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • California Cryobank
  • Bloom Fertility Centre
  • Anecova
  • CooperSurgical
  • Merck KGaA
  • Ferring B.V.
  • FUJIFILM Irvine Scientific
  • Genea Limited
  • Nidacon International AB
  • Celmatix Inc.
We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.


1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Assisted Reproductive Technology Market Overview
3.1 Global Assisted Reproductive Technology Market Historical Value (2017-2023)
3.2 Global Assisted Reproductive Technology Market Forecast Value (2024-2032)
4 Global Assisted Reproductive Technology Market Landscape
4.1 Global Assisted Reproductive Technology: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Assisted Reproductive Technology: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global Assisted Reproductive Technology Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Assisted Reproductive Technology Market Segmentation
6.1 Global Assisted Reproductive Technology Market by Procedure
6.1.1 Market Overview
6.1.2 Fresh Donor
6.1.3 Fresh Nondonor
6.1.4 Frozen Donor
6.1.5 Frozen Nondonor
6.1.6 Embryo/Egg Banking
6.2 Global Assisted Reproductive Technology Market by Age
6.2.1 Market Overview
6.2.2 Women Younger Than Age 35
6.2.3 Women Older Than Age 35
6.3 Global Assisted Reproductive Technology Market by Application
6.3.1 Market Overview
6.3.2 Artificial Insemination - Intrauterine Insemination (AI-IUI)
6.3.3 Frozen Embryo Replacement (FER)
6.3.4 Surrogacy
6.3.5 Ovulation Induction
6.3.6 Others
6.4 Global Assisted Reproductive Technology Market by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Fertility Clinics
6.4.4 Others
6.5 Global Assisted Reproductive Technology Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Assisted Reproductive Technology Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Assisted Reproductive Technology Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Assisted Reproductive Technology Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Assisted Reproductive Technology Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Assisted Reproductive Technology Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 California Cryobank
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Bloom Fertility Centre
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Anecova
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 CooperSurgical
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Merck KGaA
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Ferring B.V.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 FUJIFILM Irvine Scientific
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Genea Limited
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Nidacon International AB
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Celmatix Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings